Results 91 to 100 of about 54,406 (266)

Human Papillomavirus Vaccines and Vaccine Implementation [PDF]

Women's Health, 2008
Countries are now challenged by the rapid development of vaccines aimined at the primary prevention of infections. In the years to come, several vaccines will need to be considered as potential candidates in routine immunization programs. Recently, two new vaccines against two/four types of human papillomavirus (HPV) have been commercialized. Bivalent
Silvia, de Sanjosé, Laia, Alemany, Xavier, Castellsagué, F Xavier, Bosch   +3 more
openaire   +2 more sources

Decline in hospitalization for genital warts in the Veneto region after an HPV vaccination program: An observational study [PDF]

, 2017
BACKGROUND: Human papillomavirus (HPV) is one of the most common sexually transmitted pathogens. This observational study was conducted to estimate the trend of hospitalization for genital warts (GWs) in the Veneto region (Italy) from 2004 to 2015 ...
Baldo, Vincenzo, Baldovin, Tatjana, Bertoncello, Chiara, Buja, Alessandra, Cocchio, Silvia, Furlan, Patrizia, Saia, Mario   +6 more
core   +1 more source

Beta Human Papillomaviruses Seropositivity and the Association With Cutaneous Squamous Cell Carcinoma—A Systematic Review and Meta‐Analysis

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Cutaneous squamous cell carcinoma (cSCC) is one of the most common nonmelanoma skin cancers, with increasing incidence globally. Beta genus human papillomaviruses (β‐HPVs), particularly in immunocompromised individuals, have been implicated in the development of cSCC. However, the strength of association between β‐HPV seropositivity
Shweh Fern Loo, Ci Zhuang Teh, Wanni Chia, Choon Chiat Oh   +3 more
wiley   +1 more source

Investigating the knowledge and attitude of mothers with teenagers toward human papillomavirus vaccine injection

Journal of Education and Health Promotion
BACKGROUND: Human papillomavirus (HPV) is a large family of viruses and is considered the most common sexually transmitted infection. One of the effective and cost-effective primary prevention methods are vaccines made against the HPV.
Leila Shasti, Sayeda Zeinab Hoseinnezhad, Zohre Keshavarz, Maryam Najiabhary, Farangis Habibi, Zeinab Hamzegardeshi   +5 more
doaj   +1 more source

Human papillomavirus and HPV vaccines: a review [PDF]

, 2007
Cervical cancer, the most common cancer affecting women in developing countries, is caused by persistent infection with "high-risk" genotypes of human papillomaviruses (HPV). The most common oncogenic HPV genotypes are 16 and 18, causing approximately 70%
Castellsague, X., Claeys, P., Cutts, F. T., de Sanjose, S., Edmunds, W. J., Franceschi, S., Garnett, G., Goldenthal, K. L., Goldie, S., Harper, D. M., Markowitz, L.   +10 more
core   +3 more sources

Evaluation of the burden of HPV-related hospitalizations as a useful tool to increase awareness: 2007–2017 data from the sicilian hospital discharge records [PDF]

, 2020
In light of the implementation of human papillomavirus (HPV) prevention strategies, epidemiological studies in different geographical areas are required in order to assess the impact of HPV-related diseases.
Amato L., Amodio E., Candiloro S., Casuccio A., Costantino C., Maranto M., Marrella A., Palmeri S., Pizzo S., Restivo V., Vitale F.   +10 more
core   +1 more source

Recurrent Respiratory Papillomatosis Foundation Position Statement on the Management of Adults With RRP

The Laryngoscope, EarlyView.
ABSTRACT Objective With regulatory approval of HPV‐specific immunotherapy for recurrent respiratory papillomatosis (RRP) and growing experience with systemic bevacizumab, a management algorithm incorporating these medical treatments is warranted. Data Sources and Methods RRP Foundation (RRPF) Key Opinion Leaders offer a proposed management algorithm ...
Simon R. Best, Aaron D. Friedman, Clark A. Rosen, Robert T. Sataloff, Laura A. Matrka, H. Steven Sims, David E. Rosow, Nabil F. Saba, David G. Lott, Adam M. Klein, Ted Mau, Milan R. Amin, Kathryn A. Wikenheiser‐Brokamp, Scott M. Norberg, Kim McClellan, Geoffrey D. Young, Clint T. Allen, on behalf of the Recurrent Respiratory Papillomatosis Foundation   +17 more
wiley   +1 more source

The time has come to make cervical cancer prevention an essential part of comprehensive sexual and reproductive health services for HIV-positive women in low-income countries. [PDF]

, 2015
IntroductionHIV and cervical cancer are intersecting epidemics that disproportionately affect one of the most vulnerable populations in the world: women in low- and middle-income countries (LMICs).
Cohen, Craig R, Huchko, Megan J, Maloba, May, Nakalembe, Miriam   +3 more
core   +3 more sources

The Patient Perspective of Living With Recurrent Respiratory Papillomatosis

The Laryngoscope, EarlyView.
This study was conducted to better understand the perspectives and real‐world impact of the disease burden on patients diagnosed with recurrent respiratory papillomatosis (RRP) and caregivers who experience the disease daily. RRP results in clinical, financial, and psychosocial burdens. Increased public awareness of human papillomavirus (HPV) infection
Sara I. Pai, Walter Ochieng, Nancy Hedlund, Amanda Martino, Neha Chohan, Mir Pawlak, Edith Morais, Kim McClellan   +7 more
wiley   +1 more source

Human papillomavirus and vaccination [PDF]

Journal of the American Academy of Dermatology, 2023
Ahmad, Nofal, Al-Shimaa M, Ibrahim, Eman, Nofal, Manal, Nabil, Ayman, Marei   +4 more
openaire   +5 more sources